Politicians on the hunt for bigger and bolder ways to lower drug prices are taking aim at a far more central part of pharma's monopoly power: the patents the industry holds on its drugs.
Politicians on the hunt for bigger and bolder ways to lower drug prices are taking aim at a far more central part of pharma's monopoly power: the patents the industry holds on its drugs.